SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (389)9/15/1999 1:46:00 PM
From: dalroi  Respond to of 555
 
DAK CONCERNING LIPO
i personaly see no reason why it wouldnt be accepted "eventally"
literature seems good and lower cardiac toxicity is realy a plus
never forget that after irradiation of the mammaria interna glands there is already a certain amount of cardiac toxicity

Does options imply any other prediction
Remeber glia tanked after approval

Cheers



To: LLCF who wrote (389)9/15/1999 2:28:00 PM
From: Doc Bones  Read Replies (1) | Respond to of 555
 
Larry McMillan (?) in this weeks Barrons, "Striking Price", recommends buying LIPO straddles, the day before the hearing. Not sure if he named a price.

- Still cheerful about INCY, but my Sep 25s from a couple months back are feeling a bit down. Nasdaq is feeling confused (from INCY news headlines, my broker has the same)

"NASDAQ - Stdnger ldgre, rekyl pe fredagens uppgeng"

Doc


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News